News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vermillion Announces Date Change Of Second Quarter 2017 Financial Results And Investor Conference Call



8/4/2017 9:39:30 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

AUSTIN, Texas, Aug. 4, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will now report its second quarter 2017 financial results on Wednesday, August 9, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

Wednesday, August 9th @ 4:30pm Eastern Time

Domestic:

888-437-9274

International:

719-325-2437

Conference ID:

8515049

Webcast:

http://public.viavid.com/index.php?id=125153



Replays, Available through August 23nd

Domestic:

844-512-2921

International:

412-317-6671

Replay PIN:

8515049

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com

 

View original content:http://www.prnewswire.com/news-releases/vermillion-announces-date-change-of-second-quarter-2017-financial-results-and-investor-conference-call-300499863.html

SOURCE Vermillion, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES